{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:19:58Z","timestamp":1783635598567,"version":"3.55.0"},"reference-count":103,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T00:00:00Z","timestamp":1529020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Malignant pleural mesothelioma (MM) is a highly aggressive tumor characterized by a poor prognosis. Although its carcinogenesis mechanism has not been strictly understood, about 80% of MM can be attributed to occupational and\/or environmental exposure to asbestos fibers. The identification of non-invasive molecular markers for an early diagnosis of MM has been the subject of several studies aimed at diagnosing the disease at an early stage. The most studied biomarker is mesothelin, characterized by a good specificity, but it has low sensitivity, especially for non-epithelioid MM. Other protein markers are Fibulin-3 and osteopontin which have not, however, showed a superior diagnostic performance. Recently, interesting results have been reported for the HMGB1 protein in a small but limited series. An increase in channel proteins involved in water transport, aquaporins, have been identified as positive prognostic factors in MM, high levels of expression of aquaporins in tumor cells predict an increase in survival. MicroRNAs and protein panels are among the new indicators of interest. None of the markers available today are sufficiently reliable to be used in the surveillance of subjects exposed to asbestos or in the early detection of MM. Our aim is to give a detailed account of biomarkers available for MM.<\/jats:p>","DOI":"10.3390\/cancers10060203","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T11:21:20Z","timestamp":1529061680000},"page":"203","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0739-8798","authenticated-orcid":false,"given":"Caterina","family":"Ledda","sequence":"first","affiliation":[{"name":"Occupational Medicine, Department of Clinical and Experimental Medicine, University of Catania, Catania 95123, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Senia","sequence":"additional","affiliation":[{"name":"Occupational Medicine, Department of Clinical and Experimental Medicine, University of Catania, Catania 95123, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venerando","family":"Rapisarda","sequence":"additional","affiliation":[{"name":"Occupational Medicine, Department of Clinical and Experimental Medicine, University of Catania, Catania 95123, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,6,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/0300060513504163","article-title":"The value of inflammatory parameters in the prognosis of malignant mesothelioma","volume":"42","author":"Abakay","year":"2014","journal-title":"J. Int. Med. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.aogh.2014.09.016","article-title":"The global spread of asbestos","volume":"80","author":"Frank","year":"2014","journal-title":"Ann. Glob. Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/oem.51.12.804","article-title":"Malignant mesothelioma: Attributable risk of asbestos exposure","volume":"51","author":"Spirtas","year":"1994","journal-title":"Occup. Environ. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1001\/jamaoncol.2016.5487","article-title":"Association of asbestos exposure with malignant mesothelioma incidence in eastern China","volume":"3","author":"Mao","year":"2017","journal-title":"JAMA Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.lungcan.2005.03.002","article-title":"Asbestos and mesothelioma: Worldwide trends","volume":"49","year":"2005","journal-title":"Lung Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1183\/09031936.99.14613819","article-title":"Detection of SV40 like viral DNA and viral antigens in malignant pleural mesothelioma","volume":"14","author":"Ramael","year":"1999","journal-title":"Eur. Respir. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/(SICI)1096-9896(199803)184:3<252::AID-PATH15>3.0.CO;2-R","article-title":"SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma, and non-malignant pulmonary diseases","volume":"184","author":"Bidet","year":"1998","journal-title":"J. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00432-008-0444-9","article-title":"Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors","volume":"135","author":"Weiner","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1183\/09031936.94.07061035","article-title":"Prognostic factors and survival in malignant pleural mesothelioma","volume":"7","author":"Damhuis","year":"1994","journal-title":"Eur. Respir. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/(SICI)1097-0274(199711)32:5<445::AID-AJIM3>3.0.CO;2-R","article-title":"Pleural plaques as risk indicators for malignant pleural mesothelioma: A necropsy-based study","volume":"32","author":"Bianchi","year":"1997","journal-title":"Am. J. Ind. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/1430.15816","article-title":"Prognostic factors affecting survival in malignant pleural mesothelioma: Analysis of 125 subjects","volume":"100","author":"Komurcuoglu","year":"2014","journal-title":"Tumori"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.athoracsur.2007.11.065","article-title":"Risk Factors for Major Complications after Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma","volume":"85","author":"McRae","year":"2008","journal-title":"Ann. Thorac. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2217\/fon-2016-0337","article-title":"High risk of pleural plaques and parenchymal abnormalities in women living in biancavilla (Italy)","volume":"12","author":"Ledda","year":"2016","journal-title":"Future Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.envres.2016.05.024","article-title":"Natural carcinogenic fiber and pleural plaques assessment in a general population: A cross-sectional study","volume":"150","author":"Ledda","year":"2016","journal-title":"Environ. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1289\/ehp.001081047","article-title":"Environmental malignant mesothelioma in Southern Anatolia: A study of fifty cases","volume":"108","author":"Zeren","year":"2000","journal-title":"Environ. Health Perspect."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.3892\/ol.2015.2978","article-title":"Detection of pleural plaques in workers exposed to inhalation of natural fluoro-edenite fibres","volume":"9","author":"Rapisarda","year":"2015","journal-title":"Oncol. Lett."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.envres.2016.01.043","article-title":"Sheep lymph-nodes as a biological indicator of environmental exposure to fluoro-edenite","volume":"147","author":"Ledda","year":"2016","journal-title":"Environ. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/fon-2016-0338","article-title":"Early effects of fluoro-edenite: Correlation between IL-18 serum levels and pleural and parenchymal abnormalities","volume":"12","author":"Ledda","year":"2016","journal-title":"Future Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/1547691X.2017.1415398","article-title":"Prevalence of anti-nuclear autoantibodies in subjects exposed to natural asbestiform fibers: A cross-sectional study","volume":"15","author":"Ledda","year":"2018","journal-title":"J. Immunotoxicol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.3892\/mmr.2017.6384","article-title":"Immunomodulatory effects in workers exposed to naturally occurring asbestos fibers","volume":"15","author":"Ledda","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1180\/0026461036760160","article-title":"Characterization of amphibole fibers linked to mesothelioma in the area of Biancavilla, Eastern Sicily, Italy","volume":"67","author":"Gianfagna","year":"2003","journal-title":"Mineral. Mag."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1289\/ehp.1002862","article-title":"Pleural mesothelioma in New Caledonia: Associations with environmental risk factors","volume":"119","author":"Baumann","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/j.yrtph.2007.11.001","article-title":"Environmental mesothelioma associated with tremolite asbestos: Lessons from the experiences of Turkey, Greece, Corsica, New Caledonia and Cyprus","volume":"52","author":"Constantopoulos","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/oxfordjournals.aje.a010201","article-title":"Environmental exposure to tremolite and respiratory cancer in New Caledonia: A case-control study","volume":"151","author":"Luce","year":"2000","journal-title":"Am. J. Epidemiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.fertnstert.2016.09.005","article-title":"Mesothelial cells and peritoneal homeostasis","volume":"106","author":"Mutsaers","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3747\/pdi.2008.00273","article-title":"The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis","volume":"30","author":"Yamamoto","year":"2010","journal-title":"Peritoneal. Dial. Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.scitotenv.2012.04.043","article-title":"Resistance to asbestos-induced apoptosis with continuous exposure to crocidolite on a human T cell","volume":"429","author":"Maeda","year":"2012","journal-title":"Sci. Total Environ."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1165\/rcmb.2012-0134OC","article-title":"Effect of asbestos exposure on differentiation of cytotoxic t lymphocytes in mixed lymphocyte reaction of human peripheral blood mononuclear cells","volume":"49","author":"Nishimura","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11864-008-0067-z","article-title":"Mesothelioma epidemiology, carcinogenesis, and pathogenesis","volume":"9","author":"Yang","year":"2008","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_32","first-page":"319","article-title":"Fluoro-edenite fibres induce lung cell apoptosis: An in vivostudy","volume":"23","author":"Loreto","year":"2008","journal-title":"Histol. Histopathol."},{"key":"ref_33","first-page":"595","article-title":"Effects of exposure to fluoro-edenite fibre pollution on the respiratory system: An in vivo model","volume":"21","author":"Martinez","year":"2006","journal-title":"Histol. Histopathol."},{"key":"ref_34","first-page":"749","article-title":"Asbestos exposure and histological subtype of malignant mesothelioma","volume":"73","author":"Franklin","year":"2016","journal-title":"Occup. Environ. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00428-014-1664-9","article-title":"Reproducibility of histological subtyping of malignant pleural mesothelioma","volume":"465","author":"Seiwerth","year":"2014","journal-title":"Virchows Arch."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/JTO.0b013e31820ce2c7","article-title":"Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma","volume":"6","author":"Kao","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/PAP.0000000000000180","article-title":"Recent Advances in the Diagnosis of Malignant Mesothelioma: Focus on Approach in Challenging Cases and in Limited Tissue and Cytologic Samples","volume":"25","author":"Monaco","year":"2018","journal-title":"Adv. Anat. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Ak, G., Tada, Y., Shimada, H., Metintas, S., Ito, M., Hiroshima, K., Masatoshi, T., and Muzaffer, M. (2017). Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3209-5"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/jclinpath-2011-200208","article-title":"Genomic gains and losses in malignant mesothelioma demonstrated by FISH analysis of paraffin-embedded tissues","volume":"65","author":"Takeda","year":"2012","journal-title":"J. Clin. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MCP.0b013e32832b98eb","article-title":"Serum and pleural fluid biomarkers for mesothelioma","volume":"15","author":"Creaney","year":"2009","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0004563217741145","article-title":"Biomarkers in mesothelioma","volume":"55","author":"Arnold","year":"2018","journal-title":"Ann. Clin. Biochem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MCP.0b013e32812144bb","article-title":"Biomarkers for mesothelioma","volume":"13","author":"Scherpereel","year":"2007","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3892\/ijo.2014.2370","article-title":"Significance of osteopontin in the sensitivity of malignant pleural mesothelioma to pemetrexed","volume":"45","author":"Takeuchi","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMoa051185","article-title":"Asbestos exposure, pleural mesothelioma, and serum osteopontin levels","volume":"353","author":"Pass","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cca.2014.02.024","article-title":"Diagnostic accuracy of osteopontin for malignant pleural mesothelioma: A systematic review and meta-analysis","volume":"433","author":"Hu","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"ref_47","first-page":"2205","article-title":"Osteopontin modulates malignant pleural mesothelioma cell functions in vitro","volume":"29","author":"Ohashi","year":"2009","journal-title":"Anticancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1158\/1078-0432.CCR-06-2144","article-title":"Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment","volume":"13","author":"Grigoriu","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1309\/TWCQV536WWRNEU51","article-title":"Prognostic role of osteopontin expression in malignant pleural mesothelioma","volume":"130","author":"Cappia","year":"2008","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/172460080902400208","article-title":"Osteopontin is not a specific marker in malignant pleural mesothelioma","volume":"24","author":"Paleari","year":"2009","journal-title":"Int. J. Biol. Markers"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.hoc.2005.09.007","article-title":"Detection of malignant mesothelioma in asbestos-exposed individuals: The potential role of soluble mesothelin-related protein","volume":"19","author":"Creaney","year":"2005","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_52","first-page":"5151","article-title":"Loss of mesothelin expression by mesothelioma cells grown in vitro determines sensitivity to anti-mesothelin immunotoxin SS1P","volume":"32","author":"Zhang","year":"2012","journal-title":"Anticancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1158\/1078-0432.CCR-04-2304","article-title":"Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients","volume":"11","author":"Ho","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"46425","DOI":"10.18632\/oncotarget.17436","article-title":"Prognostic significance of soluble mesothelin in malignant pleural mesothelioma: A meta-analysis","volume":"8","author":"Tian","year":"2017","journal-title":"Oncotarget"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1164\/rccm.200907-1020OC","article-title":"Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma","volume":"181","author":"Hollevoet","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.clinbiochem.2009.03.007","article-title":"Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma","volume":"42","author":"Grigoriu","year":"2009","journal-title":"Clin. Biochem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1155\/2012\/430689","article-title":"Soluble mesothelin-related peptides levels in patients with malignant mesothelioma","volume":"32","author":"Franko","year":"2012","journal-title":"Dis. Markers"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000355687","article-title":"Is soluble mesothelin-related protein an upfront predictive marker of pleural mesothelioma? A prospective study on Italian workers exposed to asbestos","volume":"86","author":"Filiberti","year":"2014","journal-title":"Oncology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/JTO.0b013e318187491c","article-title":"Diagnostic and prognostic value of soluble mesothelin-related proteins in patients with malignant pleural mesothelioma in comparison with benign asbestosis and lung cancer","volume":"3","author":"Schneider","year":"2008","journal-title":"J. Thorac. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1515\/CCLM.2010.066","article-title":"Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: Analytical validation of ELISA based assays and characterization at mRNA and protein levels","volume":"48","author":"Rai","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1515\/raon-2015-0019","article-title":"Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma","volume":"49","author":"Kovac","year":"2015","journal-title":"Radiol. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"84851","DOI":"10.18632\/oncotarget.12707","article-title":"Diagnostic value of fibulin-3 for malignant pleural mesothelioma: A systematic review and meta-analysis","volume":"7","author":"Ren","year":"2016","journal-title":"Oncotarget"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.envres.2017.03.055","article-title":"Analysis of fibulin-3 after exposure to asbestos-like fibers","volume":"156","author":"Rapisarda","year":"2017","journal-title":"Environ. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1115050","article-title":"Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma","volume":"367","author":"Pass","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MCP.0000000000000167","article-title":"Comparison of mesothelin and fibulin-3 in pleural fluid and serum as markers in malignant mesothelioma","volume":"21","author":"Creaney","year":"2015","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2217\/fon-2017-0386","article-title":"Fibulin-3 immunoexpression in malignant mesothelioma due to fluoro-edenite: A preliminary report","volume":"14","author":"Caltabiano","year":"2018","journal-title":"Future Oncol."},{"key":"ref_67","first-page":"687","article-title":"Accuracy of fibulin-3 in the diagnosis of malignant pleural mesothelioma: A meta-analysis","volume":"29","author":"Shixian","year":"2017","journal-title":"Cancer Res. Clin."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"13030","DOI":"10.18632\/oncotarget.14712","article-title":"Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis","volume":"8","author":"Pei","year":"2017","journal-title":"Oncotarget"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/thoraxjnl-2014-205205","article-title":"Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma","volume":"69","author":"Creaney","year":"2014","journal-title":"Thorax"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.7314\/APJCP.2015.16.4.1403","article-title":"Fibulin-3 as a diagnostic biomarker in patients with malignant mesothelioma","volume":"16","author":"Kaya","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.21873\/anticanres.11460","article-title":"Comparison of the diagnostic performance of fibulin-3 and mesothelin in patients with pleural effusions from malignant mesothelioma","volume":"37","author":"Battolla","year":"2017","journal-title":"Anticancer Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/bjc.2015.286","article-title":"Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis","volume":"113","author":"Kirschner","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/fon.15.271","article-title":"FBLN-3 as a biomarker of pleural plaques in workers occupationally exposed to carcinogenic fibers: A pilot study","volume":"11","author":"Rapisarda","year":"2015","journal-title":"Future Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Tabata, C., Shibata, E., Tabata, R., Kanemura, S., Mikami, K., Nogi, Y., Masachika, E., Nishizaki, T., and Nakano, T. (2013). Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-205"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/1078-0432.CCR-15-1130","article-title":"HMGB1 and its hyperacetylated isoform are sensitive and specific serum biomarkers to detect asbestos exposure and to identify mesothelioma patients","volume":"22","author":"Napolitano","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1158\/0008-5472.CAN-11-3481","article-title":"Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma","volume":"72","author":"Jube","year":"2012","journal-title":"Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/his.13470","article-title":"Expression analysis of HMGB1 in histological samples of malignant pleural mesothelioma","volume":"72","author":"Rrapaj","year":"2018","journal-title":"Histopathology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"5756102","DOI":"10.1155\/2017\/5756102","article-title":"Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases","volume":"2017","author":"Ying","year":"2017","journal-title":"Dis. Markers"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"50417","DOI":"10.18632\/oncotarget.10413","article-title":"HMGB1 overexpression as a prognostic factor for survival in cancer: A meta-analysis and systematic review","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.gene.2012.12.075","article-title":"Gene expression profile of aquaporin 1 and associated interactors in malignant pleural mesothelioma","volume":"517","author":"Jagirdar","year":"2013","journal-title":"Gene"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Driml, J., Pulford, E., Moffat, D., Karapetis, C., Kao, S., Griggs, K., Henderson, D.W., and Klebe, S. (2016). Usefulness of aquaporin 1 as a prognostic marker in a prospective cohort of malignant mesotheliomas. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17071041"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.mam.2012.06.001","article-title":"The first discovered water channel protein, later called aquaporin 1: Molecular characteristics, functions and medical implications","volume":"33","author":"Benga","year":"2012","journal-title":"Mol. Asp. Med."},{"key":"ref_83","first-page":"451","article-title":"Overexpression of aquaporin-1 in lung adenocarcinomas and pleural mesotheliomas","volume":"26","author":"Silva","year":"2011","journal-title":"Histol. Histopathol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1002\/cncr.26497","article-title":"Aquaporin 1 is an independent prognostic factor in pleural malignant mesothelioma","volume":"118","author":"Kao","year":"2012","journal-title":"Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"286719","DOI":"10.1155\/2015\/286719","article-title":"Blockade of aquaporin 1 inhibits proliferation, motility, and metastatic potential of mesothelioma in vitro but not in an in vivo model","volume":"2015","author":"Klebe","year":"2015","journal-title":"Dis. Markers"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Pulford, E., McEvoy, J., Hocking, A., Prabhakaran, S., Griggs, K., and Klebe, S. (2017). The effect of aquaporin 1-inhibition on vasculogenic mimicry in malignant mesothelioma. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18112293"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"7375","DOI":"10.1007\/s13277-015-4063-1","article-title":"Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma","volume":"36","author":"Liu","year":"2015","journal-title":"Tumor Biol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Angelico, G., Caltabiano, R., Loreto, C., Ieni, A., Tuccari, G., Ledda, C., and Rapisarda, V. (2018). Immunohistochemical expression of aquaporin-1 in fluoro-edenite-induced malignant mesothelioma: A preliminary report. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030685"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/fon-2017-0389","article-title":"Occupational exposure to fluoro-edenite and prevalence of anti-nuclear autoantibodies","volume":"14","author":"Rapisarda","year":"2018","journal-title":"Future Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/oem.2005.020727","article-title":"Monitoring of fluoro-edenite fibre pollution through the study of sheep lymph nodes as a model of a biological indicator","volume":"62","author":"Rapisarda","year":"2005","journal-title":"Occup. Environ. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"78193","DOI":"10.18632\/oncotarget.20409","article-title":"Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma","volume":"8","author":"Birnie","year":"2017","journal-title":"Oncotarget"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.arcmed.2016.08.009","article-title":"Malignant pleural mesothelioma: The need to move from research to clinical practice","volume":"47","author":"Ledda","year":"2016","journal-title":"Arch. Med. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"68627","DOI":"10.18632\/oncotarget.19800","article-title":"Downregulation of miR-99a\/let-7c\/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma","volume":"8","author":"Truini","year":"2017","journal-title":"Oncotarget"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Weber, D.G., Johnen, G., Bryk, O., J\u00f6ckel, K., and Br\u00fcning, T. (2012). Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma\u2014A pilot study. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030221"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00428-017-2133-z","article-title":"miRNA regulation is important for DNA damage repair and recognition in malignant pleural mesothelioma","volume":"470","author":"Mairinger","year":"2017","journal-title":"Virchows Arch."},{"key":"ref_96","first-page":"740","article-title":"Identification of circulating miRNA profiles that distinguish malignant pleural mesothelioma from lung adenocarcinoma","volume":"13","year":"2014","journal-title":"EXCLI J."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Cavalleri, T., Angelici, L., Favero, C., DIoni, L., Mensi, C., Bareggi, C., Alessandro, P., Arianna, R., Dario, C., and Lorenzo, B. (2017). Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and Asbestos-Exposed subjects suggest a 2-miRNA signature as potential biomarker of disease. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0176680"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Lamberti, M., Capasso, R., Lombardi, A., Di Domenico, M., Fiorelli, A., Feola, A., Alessandra, F.P., Mario, S., Michele, C., and Diego, I. (2015). Two different serum MiRNA signatures correlate with the clinical outcome and histological subtype in pleural malignant mesothelioma patients. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135331"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1586\/ers.10.17","article-title":"Translational therapies for malignant pleural mesothelioma","volume":"4","author":"Belli","year":"2010","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/JTO.0b013e31820db125","article-title":"MicroRNAs dysregulation in human malignant pleural mesothelioma","volume":"6","author":"Balatti","year":"2011","journal-title":"J. Thorac Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"9645940","DOI":"10.1155\/2017\/9645940","article-title":"MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study","volume":"2017","author":"Mozzoni","year":"2017","journal-title":"Dis. Markers"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1038\/s41598-017-02694-0","article-title":"Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism","volume":"7","author":"Melaiu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Rivera, V., Negrete-Garc\u00eda, M.C., \u00c1vila-Moreno, F., and Ortiz-Quintero, B. (2018). Secreted and tissue miRNAs as diagnosis biomarkers of malignant pleural mesothelioma. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020595"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/10\/6\/203\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:08:52Z","timestamp":1760195332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/10\/6\/203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,15]]},"references-count":103,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["cancers10060203"],"URL":"https:\/\/doi.org\/10.3390\/cancers10060203","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,15]]}}}